SanofiSanofiSanofi

Sanofi

No trades
See on Supercharts

Key facts today

CIC Market Solutions upgraded Sanofi to a 'buy' rating from 'neutral' while maintaining its price target at 110 euros.
Analyze the impactAnalyze the impact
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪119.98 B‬USD
3.61USD
‪5.96 B‬USD
‪47.54 B‬USD
‪1.12 B‬
Beta (1Y)
0.43
Employees (FY)
‪87.99 K‬
Change (1Y)
‪−3.58 K‬ −3.91%
Revenue / Employee (1Y)
‪540.24 K‬USD
Net income / Employee (1Y)
‪67.73 K‬USD

About SANOFI


CEO
Paul Hudson
Headquarters
Paris
Website
Founded
1994
ISIN
FR0000120578
FIGI
BBG000CZ8S80
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US801060AD6
SANOFI SA 18/28
Yield to maturity
4.84%
Maturity date
Jun 19, 2028
FR1332437
SANOFI 18/38 MTN
Yield to maturity
3.31%
Maturity date
Mar 21, 2038
FR1340985
SANOFI 19/34 MTN
Yield to maturity
3.03%
Maturity date
Mar 21, 2034
FR1332435
SANOFI 18/30 MTN
Yield to maturity
2.96%
Maturity date
Mar 21, 2030
FR14009KS
SANOFI 22/25 MTN
Yield to maturity
2.88%
Maturity date
Apr 6, 2025
FR1350510
SANOFI 20/25 MTN
Yield to maturity
2.81%
Maturity date
Apr 1, 2025
FR1350511
SANOFI 20/30 MTN
Yield to maturity
2.78%
Maturity date
Apr 1, 2030
FR14009KQ
SANOFI 22/29 MTN
Yield to maturity
2.77%
Maturity date
Apr 6, 2029
FR1340984
SANOFI 19/29 MTN
Yield to maturity
2.76%
Maturity date
Mar 21, 2029
FR1332434
SANOFI 18/26 MTN
Yield to maturity
2.69%
Maturity date
Mar 21, 2026
FR1214680
SANOFI 14/26 MTN
Yield to maturity
2.59%
Maturity date
Sep 10, 2026

Explore more bonds 

Frequently Asked Questions


The current price of SNYNF is 95.50 USD — it has decreased by −0.12% in the past 24 hours. Watch Sanofi stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Sanofi stocks are traded under the ticker SNYNF.
SNYNF stock has fallen by −1.14% compared to the previous week, the month change is a −11.29% fall, over the last year Sanofi has showed a 3.42% increase.
We've gathered analysts' opinions on Sanofi future price: according to them, SNYNF price has a max estimate of 132.84 USD and a min estimate of 94.89 USD. Watch SNYNF chart and read a more detailed Sanofi stock forecast: see what analysts think of Sanofi and suggest that you do with its stocks.
SNYNF reached its all-time high on Sep 11, 2024 with the price of 119.65 USD, and its all-time low was 15.66 USD and was reached on Jan 15, 2009. View more price dynamics on SNYNF chart.
See other stocks reaching their highest and lowest prices.
SNYNF stock is 0.31% volatile and has beta coefficient of 0.43. Track Sanofi stock price on the chart and check out the list of the most volatile stocks — is Sanofi there?
Today Sanofi has the market capitalization of ‪119.31 B‬, it has decreased by −3.69% over the last week.
Yes, you can track Sanofi financials in yearly and quarterly reports right on TradingView.
Sanofi is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
SNYNF net income for the last half-year is ‪2.41 B‬ USD, while the previous report showed ‪2.17 B‬ USD of net income which accounts for 10.64% change. Track more Sanofi financial stats to get the full picture.
Yes, SNYNF dividends are paid annually. The last dividend per share was 4.06 USD. As of today, Dividend Yield (TTM)% is 4.14%. Tracking Sanofi dividends might help you take more informed decisions.
Sanofi dividend yield was 4.19% in 2023, and payout ratio reached 87.16%. The year before the numbers were 3.96% and 53.24% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 23, 2024, the company has ‪87.99 K‬ employees. See our rating of the largest employees — is Sanofi on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sanofi EBITDA is ‪14.81 B‬ USD, and current EBITDA margin is 30.09%. See more stats in Sanofi financial statements.
Like other stocks, SNYNF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sanofi stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sanofi technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sanofi stock shows the sell signal. See more of Sanofi technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.